Accelerating Breakthrough Discoveries into Medicines

David Shaywitz

David Shaywitz, MD, PhD

David Shaywitz headshot.jpg

David's career focus has been translating promising science into clinical impact. He trained as physician-scientist at Harvard and MIT, did his medicine and endocrinology training at MGH, and his post-doc in the Melton Lab at the Harvard Stem Cell Institute. He spent the following decade in and around pharma including several years in experimental medicine at Merck, several years at BCG, and several years at Theravance in South San Francisco. From 2014-2017, he was the Chief Medical Officer of the cloud genomics company, DNAnexus. David is passionate about the opportunities at the intersection of technology and health; at Takeda Ventures, which he joined as a Senior Partner in 2017, he is building out a data science and technology (DST) capability. David also writes about issues related to entrepreneurship, technology, innovation, and medicine, including occasional commentaries for WSJ, FT, WaPo, etc, and writes a regular blog at Forbes. Since 2015 he has co-hosted a twice-monthly podcast on tech & health, "Tech Tonics," with Lisa Suennen.